مركز الاختبار والتطبيق الوطني للذكاء الاصطناعي في شنغهاي: الإعلان عن خمسة إنجازات ابتكارية رئيسية

Mars Finance News 28 March, news, the National Artificial Intelligence Application Shanghai Pilot Base held a summary conference of phased results on March 28 at the Zhongshan Hospital affiliated to Fudan University, releasing five core innovative results and nine medical intelligent applications, effectively promoting the high-quality development of “Artificial Intelligence + Healthcare” in China. Among them, the five core phased results are: 1. Relying on the construction of an integrated new computing power service platform covering computing, storage, network, and development toolchains, forming a computing resource base that connects “model development—verification iteration—inference service—security governance”, breaking through technical adaptation barriers, achieving “national models with national chips”, with performance comparable to international first-class computing power levels; 2. Launching six major vertical basic medical models, creating a full-stack independently controllable multi-modal large model matrix, covering diverse clinical scenarios such as imaging, pathology, traditional Chinese medicine, and scientific research, with several medical large models reaching internationally leading levels; 3. Establishing a national demonstrative medical AI data infrastructure, gathering massive amounts of high-quality three medical data, solidifying the core foundation for model training and iteration; 4. Creating the globally leading Chinese medical large model testing platform MedBench 4.0, establishing authoritative and unified industry evaluation standards; 5. Selecting and promoting world-class medical intelligent applications across multiple disciplines and scenarios, promoting cutting-edge technologies to quickly land in clinical front lines from laboratories. At this press conference, nine medical intelligent applications were also highlighted, covering areas such as clinical diagnosis and treatment, equipment development, AI pharmaceuticals, and brain-computer interfaces. As of now, the Shanghai Pilot Base has launched several intelligent agents such as cardiovascular disease “Guanxin”, liver and gallbladder tumors, chest imaging one scan multiple checks, golden coders, and hospital-wide electronic medical record generation. Among them, the intelligent agent for liver and gallbladder tumors has been promoted to 122 medical institutions, serving over one million people; the chest imaging one scan multiple checks intelligent agent has processed over 2.5 million cases cumulatively, covering more than 20 hospitals nationwide, significantly improving clinical efficiency and diagnostic accuracy. The National Artificial Intelligence Application Shanghai Pilot Base (in the medical field) is a key carrier for implementing national strategies and creating a global highland for medical AI applications, promoting medical AI from point breakthroughs to system integration. (CCTV News)